These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27067450)

  • 1. The RP105/MD-1 complex: molecular signaling mechanisms and pathophysiological implications.
    Schultz TE; Blumenthal A
    J Leukoc Biol; 2017 Jan; 101(1):183-192. PubMed ID: 27067450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
    Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
    J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of mouse and human RP105/MD-1 complexes reveal unique dimer organization of the toll-like receptor family.
    Ohto U; Miyake K; Shimizu T
    J Mol Biol; 2011 Nov; 413(4):815-25. PubMed ID: 21959264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced IgG production in TLR-activated human primary B cells involves ULK1-mediated autophagy.
    Eriksen AB; Torgersen ML; Holm KL; Abrahamsen G; Spurkland A; Moskaug JØ; Simonsen A; Blomhoff HK
    Autophagy; 2015; 11(3):460-71. PubMed ID: 25749095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor Mediated Activation of Natural Autoantibody Producing B Cell Subpopulations in an Autoimmune Disease Model.
    Erdő-Bonyár S; Rapp J; Minier T; Ráth G; Najbauer J; Czirják L; Németh P; Berki T; Simon D
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment.
    Singh AR; Peirce SK; Joshi S; Durden DL
    Exp Cell Res; 2014 Sep; 327(1):78-90. PubMed ID: 24881819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S; Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Tsuneyama K; Hirai Y; Takatsu K
    Mol Immunol; 2012 Jan; 49(4):611-20. PubMed ID: 22118968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toll-like receptor family protein RP105/MD1 complex is involved in the immunoregulatory effect of exopolysaccharides from Lactobacillus plantarum N14.
    Murofushi Y; Villena J; Morie K; Kanmani P; Tohno M; Shimazu T; Aso H; Suda Y; Hashiguchi K; Saito T; Kitazawa H
    Mol Immunol; 2015 Mar; 64(1):63-75. PubMed ID: 25466614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.
    Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
    Nat Immunol; 2005 Jun; 6(6):571-8. PubMed ID: 15852007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
    Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of RP105 and toll-like receptors in the activation of mouse peritoneal macrophages by Staphylococcus aureus.
    Liu B; Fu Y; Feng S; Zhang X; Liu Z; Cao Y; Li D; Liang D; Li F; Zhang N; Yang Z
    Scand J Immunol; 2013 Jul; 78(1):8-16. PubMed ID: 23521167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases.
    Fan Z; Pathak JL; Ge L
    Front Cell Dev Biol; 2021; 9():713254. PubMed ID: 34414191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.
    Hamerman JA; Pottle J; Ni M; He Y; Zhang ZY; Buckner JH
    Immunol Rev; 2016 Jan; 269(1):212-27. PubMed ID: 26683155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of lupus-like nephritis through autoimmune antibody produced by CD180-negative B lymphocytes in NZBWF1 mouse.
    Fujita K; Akasaka Y; Kuwabara T; Wang B; Tanaka K; Kamata I; Yokoo T; Kinoshita T; Iuchi A; Akishima-Fukasawa Y; Ishikawa Y; Kondo M; Ishii T
    Immunol Lett; 2012 May; 144(1-2):1-6. PubMed ID: 22387632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 19. Signaling mechanisms regulating B-lymphocyte activation and tolerance.
    Hobeika E; Nielsen PJ; Medgyesi D
    J Mol Med (Berl); 2015 Feb; 93(2):143-58. PubMed ID: 25627575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity.
    Fujimoto M; Sato S
    J Dermatol Sci; 2007 Apr; 46(1):1-9. PubMed ID: 17223015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.